Search
for
Sort by
Research 271–300 of 492
- Deteksi Dini dan Pencegahan Risiko Bunuh Diri pada Remaja
- Re: Association of Suicidality and Depression with 5α-Reductase Inhibitors
- Reframing the Discussion on Finasteride and Neuropsychiatric Safety
- Suicidal ideation in patients undergoing treatment with 5α-reductase inhibitors
- Finasteride-Induced Neuropsychiatric Reactions
- Depressive Symptoms and Suicidal Thoughts Among Former Users of Finasteride With Persistent Sexual Side Effects
- Young patients using finasteride exhibit risk of suicidality
- Anabolic-androgenic steroids and cardiovascular risk
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Do Sexual Orientation Change Efforts (SOCE) increase suicidal risk for sexual minorities?: An exchange
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Risk of Depression Associated With Finasteride Treatment
- Transgender health and the impact of aging and menopause
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- Research gaps in medical treatment of transgender/nonbinary people
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Pimples and pustules in diabetes
- Transgender adolescents and acne: A cases series
- Complex X chromosome rearrangement associated with multiorgan autoimmunity
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Epidemiology and burden of alopecia areata: a systematic review
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Divalproex-Induced Alopecia: A Case Report
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms
- Cutaneous Signs of Malnutrition Secondary to Eating Disorders
- Comparison of clinical trials with finasteride and dutasteride.
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS